[1] Pham T C, Nguyen V N, Choi Y et al. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy[J]. Chemical Reviews, 121, 13454-13619(2021).

[2] Zhao X Z, Liu J P, Fan J L et al. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application[J]. Chemical Society Reviews, 50, 4185-4219(2021).

[3] Zhang Z J, Kang M M, Tan H et al. The fast-growing field of photo-driven theranostics based on aggregation-induced emission[J]. Chemical Society Reviews, 51, 1983-2030(2022).

[4] Wu W B, Mao D, Xu S D et al. Polymerization-enhanced photosensitization[J]. Chem, 4, 1937-1951(2018).

[5] Gao J C, Tian Y, Li Y G et al. Design strategies for aggregation-induced emission photosensitizers with enhanced safety in photodynamic therapy[J]. Coordination Chemistry Reviews, 507, 215756(2024).

[6] Deng Z Q, Li H C, Chen S et al. Near-infrared-activated anticancer platinum (IV) complexes directly photooxidize biomolecules in an oxygen-independent manner[J]. Nature Chemistry, 15, 930-939(2023).

[7] Wang Y W, Li Y M, Zhang Z J et al. Triple-jump photodynamic theranostics: MnO2 combined upconversion nanoplatforms involving a type-I photosensitizer with aggregation-induced emission characteristics for potent cancer treatment[J]. Advanced Materials, 33, e2103748(2021).

[8] Zhang T F, Zhang J Y, Wang F B et al. Mitochondria-targeting phototheranostics by aggregation-induced NIR-II emission luminogens: modulating intramolecular motion by electron acceptor engineering for multi-modal synergistic therapy[J]. Advanced Functional Materials, 32, 2110526(2022).

[9] Kwon N, Kim H, Li X S et al. Supramolecular agents for combination of photodynamic therapy and other treatments[J]. Chemical Science, 12, 7248-7268(2021).

[10] Tian Y, Wang L, Qian Y Y et al. DNA-targeting bioactive photosensitizer for chemo-photodynamic therapy of malignant tumor[J]. ACS Materials Letters, 6, 969-975(2024).

[11] Wu B R, Kenry, Hu F. Targeted antibacterial photodynamic therapy with aggregation-induced emission photosensitizers[J]. Interdisciplinary Medicine, 2, e20230038(2024).

[12] Zhang C, Ren E, Pang X et al. Recent advances in nanophotosensitizers for antibacterial photodynamic therapy[J]. Chinese Journal of Lasers, 47, 0207012(2020).

[13] Zhuang J H, Qi G B, Feng Y C et al. Thymoquinone as an electron transfer mediator to convert Type II photosensitizers to Type I photosensitizers[J]. Nature Communications, 15, 4943(2024).

[14] Liu K N, Li R, Liu R F et al. Translation and innovation of photosensitizers[J]. Chinese Journal of Lasers, 51, 0907007(2024).

[15] Zhang J X, Zhou F, He Z Y et al. AIEgen intercalated nanoclay-based photodynamic/chemodynamic theranostic platform for ultra-efficient bacterial eradication and fast wound healing[J]. ACS Applied Materials & Interfaces, 14, 30533-30545(2022).

[16] Hu X L, Zhao X Q, He B Z et al. A simple approach to bioconjugation at diverse levels: metal-free click reactions of activated alkynes with native groups of biotargets without prefunctionalization[J]. Research, 2018, 3152870(2018).

[17] Wang D, Lee M M S, Xu W H et al. Boosting non-radiative decay to do useful work: development of a multi-modality theranostic system from an AIEgen[J]. Angewandte Chemie (International Ed), 58, 5628-5632(2019).

[18] Jablonski A. Efficiency of anti-stokes fluorescence in dyes[J]. Nature, 131, 839-840(1933).

[19] Kasha M. Energy transfer mechanisms and the molecular exciton model for molecular aggregates[J]. Radiation Research, 20, 55-70(1963).

[20] Hu Y X, Yu J, Xu M K et al. Bienzyme-locked activatable fluorescent probes for specific imaging of tumor-associated mast cells[J]. Journal of the American Chemical Society, 146, 12656-12663(2024).

[21] Sharma A, Verwilst P, Li M L et al. Theranostic fluorescent probes[J]. Chemical Reviews, 124, 2699-2804(2024).

[22] Wang X Z, He S S, Cheng P H et al. A dual-locked tandem fluorescent probe for imaging of pyroptosis in cancer chemo-immunotherapy[J]. Advanced Materials, 35, 2206510(2023).

[23] Zhang J, Pan Y H, He C X et al. Progress of type I organic photosensitizers for photodynamic therapy[J]. Chinese Journal of Lasers, 51, 1507201(2024).

[24] Kang M M, Zhang Z J, Xu W H et al. Good steel used in the blade: well-tailored type-I photosensitizers with aggregation-induced emission characteristics for precise nuclear targeting photodynamic therapy[J]. Advanced Science, 8, 2100524(2021).

[25] Wang B, Tang D S, Karges J et al. A NIR-II fluorescent PolyBodipy delivering cationic Pt-NHC with type II immunogenic cell death for combined chemotherapy and photodynamic immunotherapy[J]. Advanced Functional Materials, 33, 2214824(2023).

[26] Li B, Wang W, Zhao L et al. Multifunctional AIE nanosphere-based “nanobomb” for trimodal imaging-guided photothermal/photodynamic/pharmacological therapy of drug-resistant bacterial infections[J]. ACS Nano, 17, 4601-4618(2023).

[27] Qiao W G, Ma T, Xie G et al. Supramolecular H-aggregates of squaraines with enhanced type I photosensitization for combined photodynamic and photothermal therapy[J]. ACS Nano, 18, 25671-25684(2024).

[28] Zha K K, Zhang W Q, Hu W X et al. Three-step regenerative strategy: multifunctional bilayer hydrogel for combined photothermal/photodynamic therapy to promote drug-resistant bacteria-infected wound healing[J]. Advanced Functional Materials, 34, 2308145(2024).

[29] Bai L Y, Shi E Y, Li Y N et al. Oxyhemoglobin-based nanophotosensitizer for specific and synergistic photothermal and photodynamic therapies against porphyromonas gingivalis oral infection[J]. ACS Biomaterials Science & Engineering, 9, 485-497(2023).

[30] Tang F, Ding A X, Xu Y et al. Gene and photothermal combination therapy: principle, materials, and amplified anticancer intervention[J]. Small, 20, 2307078(2024).

[31] Handy R D, Shaw B J. Toxic effects of nanoparticles and nanomaterials: implications for public health, risk assessment and the public perception of nanotechnology[J]. Health, 9, 125-144(2007).

[32] Kenry, Liu B. Recent advances in biodegradable conducting polymers and their biomedical applications[J]. Biomacromolecules, 19, 1783-1803(2018).

[33] Medina C, Santos-Martinez M J, Radomski A et al. Nanoparticles: pharmacological and toxicological significance[J]. British Journal of Pharmacology, 150, 552-558(2007).

[34] Lyu Y, Zeng J F, Jiang Y Y et al. Enhancing both biodegradability and efficacy of semiconducting polymer nanoparticles for photoacoustic imaging and photothermal therapy[J]. ACS Nano, 12, 1801-1810(2018).

[35] Owens D E, Peppas N A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles[J]. International Journal of Pharmaceutics, 307, 93-102(2006).

[36] Jiang X Y, Du B J, Zheng J. Glutathione-mediated biotransformation in the liver modulates nanoparticle transport[J]. Nature Nanotechnology, 14, 874-882(2019).

[37] Montgomery S, Worswick S. Photosensitizing drug reactions[J]. Clinics in Dermatology, 40, 57-63(2022).

[38] Allison R R, Sibata C H. Oncologic photodynamic therapy photosensitizers: a clinical review[J]. Photodiagnosis and Photodynamic Therapy, 7, 61-75(2010).

[39] Liu Y S, Li Y, Koo S et al. Versatile types of inorganic/organic NIR-IIa/IIb fluorophores: from strategic design toward molecular imaging and theranostics[J]. Chemical Reviews, 122, 209-268(2022).

[40] Longmire M, Choyke P L, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats[J]. Nanomedicine, 3, 703-717(2008).

[41] Ehlerding E B, Chen F, Cai W B. Biodegradable and renal clearable inorganic nanoparticles[J]. Advanced Science, 3, 1500223(2016).

[42] Chen X L, Li M M, Lin M Z et al. Current and promising applications of Hf (iv)-based MOFs in clinical cancer therapy[J]. Journal of Materials Chemistry B, 11, 5693-5714(2023).

[43] Fox M E, Szoka F C, Fréchet J M J. Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture[J]. Accounts of Chemical Research, 42, 1141-1151(2009).

[44] Cheng P H, Pu K Y. Molecular imaging and disease theranostics with renal-clearable optical agents[J]. Nature Reviews Materials, 6, 1095-1113(2021).

[45] Zhang R J, Ji D K, Yao D F et al. Molecular engineering of aptamer to solubilize hydrophobic near-infrared photosensitizer for enhanced cancer photodynamic therapy[J]. CCS Chemistry, 6, 1240-1254(2024).

[46] Duan X C, Zhang G Q, Ji S L et al. Activatable persistent luminescence from porphyrin derivatives and supramolecular probes with imaging-modality transformable characteristics for improved biological applications[J]. Angewandte Chemie (International Ed), 61, e202116174(2022).

[47] Siwawannapong K, Zhang R, Lei H L et al. Ultra-small pyropheophorbide: a nanodots for near-infrared fluorescence/photoacoustic imaging-guided photodynamic therapy[J]. Theranostics, 10, 62-73(2020).

[48] Du B J, Jiang X Y, Huang Y Y et al. Tailoring kidney transport of organic dyes with low-molecular-weight PEGylation[J]. Bioconjugate Chemistry, 31, 241-247(2020).

[49] Zhang D S, Teng K X, Zhao L Y et al. Ultra-small nano-assemblies as tumor-targeted and renal clearable theranostic agent for photodynamic therapy[J]. Advanced Materials, 35, e2209789(2023).

[50] Zhao Y Y, Zhang X J, Xu Y H et al. A renal clearable nano-assembly with Förster resonance energy transfer amplified superoxide radical and heat generation to overcome hypoxia resistance in phototherapeutics[J]. Angewandte Chemie (International Ed), 63, e202411514(2024).

[51] Finkel T. Signal transduction by reactive oxygen species[J]. The Journal of Cell Biology, 194, 7-15(2011).

[52] Bartosz G. Reactive oxygen species: destroyers or messengers?[J]. Biochemical Pharmacology, 77, 1303-1315(2009).

[53] Wu W B, Shi L L, Duan Y K et al. Metabolizable photosensitizer with aggregation-induced emission for photodynamic therapy[J]. Chemistry of Materials, 33, 5974-5980(2021).

[54] Zhu M L, Zhang H, Ran G L et al. Bioinspired design of seco-chlorin photosensitizers to overcome phototoxic effects in photodynamic therapy[J]. Angewandte Chemie (International Ed), 61, e202204330(2022).

[55] Yuan B, Wu H, Wang H et al. A self-degradable supramolecular photosensitizer with high photodynamic therapeutic efficiency and improved safety[J]. Angewandte Chemie (International Ed), 60, 706-710(2021).

[56] Repenko T, Rix A, Ludwanowski S et al. Bio-degradable highly fluorescent conjugated polymer nanoparticles for bio-medical imaging applications[J]. Nature Communications, 8, 470(2017).

[57] Huang H Y, Xie W S, Wan Q et al. A self-degradable conjugated polymer for photodynamic therapy with reliable postoperative safety[J]. Advanced Science, 9, 2104101(2022).

[58] Huang H Y, Xie W S, Hu D N et al. Type I photodynamic therapy with a self-degradable conjugated polyelectrolyte in combination with CpG adjuvant for cancer immunotherapy[J]. Chemical Engineering Journal, 451, 138617(2023).

[59] Gao J C, Yang H, Lu Y R et al. Anthracene-bridged photosensitizers for effective and safe photodynamic therapy[J]. Chemistry of Materials, 35, 1229-1237(2023).

[60] Wang C F, Sun Y J, Huang S J et al. Self-immolative photosensitizers for self-reported cancer phototheranostics[J]. Journal of the American Chemical Society, 145, 13099-13113(2023).

[61] Huang X Y, Gu R, Li J W et al. Diketopyrrolopyrrole-Au(I) as singlet oxygen generator for enhanced tumor photodynamic and photothermal therapy[J]. Science China Chemistry, 63, 55-64(2020).

[62] Feng L N, Li C B, Liu L X et al. Acceptor planarization and donor rotation: a facile strategy for realizing synergistic cancer phototherapy via type I PDT and PTT[J]. ACS Nano, 16, 4162-4174(2022).

[63] Jiang L H, Miao X F, Zhang M Y et al. Near infrared-II excited triplet fusion upconversion with anti-Stokes shift approaching the theoretical limit[J]. Journal of the American Chemical Society, 146, 10785-10797(2024).

[64] Wang Q, Gan Z H, Shi Q K et al. A biodegradable semiconducting polymer phototherapeutic agent for safe cancer phototherapy[J]. Journal of Controlled Release, 368, 265-274(2024).

[65] Li Y G, Lin X, Jiang Y J et al. Suitable isolation side chains: a simple strategy for simultaneously improving the phototherapy efficacy and biodegradation capacities of conjugated polymer nanoparticles[J]. Nano Letters, 24, 3386-3394(2024).

[66] Gu X X, Shen J L, Xu Z W et al. Rational design of biodegradable semiconducting polymer nanoparticles for NIR-II fluorescence imaging-guided photodynamic therapy[J]. Nano Research, 17, 5399-5408(2024).

[67] Li Y G, Zhang P, Xie Y J et al. Photosensitizers with multiple degradation modes for efficient and postoperatively safe photodynamic therapy[J]. Biomaterials, 299, 122182(2023).

[68] Tang D S, Yu Y J, Zhang J B et al. Self-sacrificially degradable pseudo-semiconducting polymer nanoparticles that integrate NIR-II fluorescence bioimaging, photodynamic immunotherapy, and photo-activated chemotherapy[J]. Advanced Materials, 34, 2203820(2022).

[69] Yu Y J, Tang D S, Liu C Y et al. Biodegradable polymer with effective near-infrared-II absorption as a photothermal agent for deep tumor therapy[J]. Advanced Materials, 34, 2105976(2022).

[70] Zhou H L, Tang D S, Kang X X et al. Degradable pseudo conjugated polymer nanoparticles with NIR-II photothermal effect and cationic quaternary phosphonium structural bacteriostasis for anti-infection therapy[J]. Advanced Science, 9, 2200732(2022).

[71] Wan J, Zhang X H, Tang D S et al. Biodegradable NIR-II pseudo conjugate polymeric nanoparticles amplify photodynamic immunotherapy via alleviation of tumor hypoxia and tumor-associated macrophage reprogramming[J]. Advanced Materials, 35, 2209799(2023).